RC

Rashi Chaturvedi

Active Director Director DIN 10845002
DIN 10845002 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Rashi Chaturvedi

Data last updated:

Rashi Chaturvedi is a Director at Klug Pharmaceuticals Private Limited (since 2025). The company operates in Pharma. Klug Pharmaceuticals Private Limited reported revenue of ₹4.5 Lakh (FY 2024).

DIN 10845002
Primary Designation Director
Industry Pharma
First Appointment 01 Sep 2025
Largest company Klug Pharmaceuticals Private Limited · ₹4.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Klug Pharmaceuticals Private Limited U24232RJ2014PTC045576
Director01 Sep 2025₹4.5 Lakh (FY 2024)Active

Board colleagues of Rashi Chaturvedi

Directorship timeline

Open interactive timeline →
Klug Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rashi Chaturvedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rashi Chaturvedi

Rashi Chaturvedi currently holds 1 directorship: Klug Pharmaceuticals Private Limited (Director, since 01 Sep 2025, revenue ₹4.5 Lakh (FY 2024)).

Rashi Chaturvedi was first appointed on 01 Sep 2025 as Director at Klug Pharmaceuticals Private Limited.

The current boards of Rashi Chaturvedi's companies include Ritvik Chaturvedi (Klug Pharmaceuticals Private Limited), Saatvik Chaturvedi (Klug Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available